Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Food, Health and Nutrition | 480.2 | 397.3 | 376.7 | 394.8 | | | | |
| Industrial Specialties | 260.6 | 262.7 | 278.3 | 319.6 | | | | |
| Other Segments | 61.1 | 62.0 | 70.4 | 74.7 | | | | |
| Total revenues [+] | 801.8 | 722.0 | 725.3 | 789.1 | 839.2 | 844.1 | 862.4 | 810.5 |
| Products | | | | 789.1 | | | | |
| Net interest income | | | | | | 1.0 | 0.1 | 0.2 |
| Revenue growth [+] | 11.1% | -0.5% | -8.1% | -6.0% | -0.6% | -2.1% | 6.4% | 13.5% |
| Food, Health and Nutrition | 20.9% | 5.5% | -4.6% | | | | | |
| Industrial Specialties | -0.8% | -5.6% | -12.9% | | | | | |
| Other Segments | -1.5% | -11.9% | -5.8% | | | | | |
| Cost of goods sold | 658.5 | 573.0 | 575.0 | 645.8 | 651.7 | 685.8 | 685.0 | 605.2 |
| Gross profit | 143.4 | 149.0 | 150.4 | 143.3 | 187.5 | 158.3 | 177.4 | 205.3 |
| Gross margin | 17.9% | 20.6% | 20.7% | 18.2% | 22.3% | 18.8% | 20.6% | 25.3% |
| Selling, general and administrative | 81.1 | 82.3 | 67.4 | 87.3 | 76.0 | 70.5 | 64.3 | 65.4 |
| Research and development | 5.1 | 3.7 | 3.7 | 4.5 | 4.6 | 3.9 | 3.1 | 2.9 |
| EBITDA [+] | 102.1 | 103.4 | 116.7 | 90.1 | 142.3 | 119.3 | 152.3 | 180.7 |
| EBITDA growth | -1.2% | -11.4% | 29.6% | -36.7% | 19.2% | -21.7% | -15.7% | 24.7% |
| EBITDA margin | 12.7% | 14.3% | 16.1% | 11.4% | 17.0% | 14.1% | 17.7% | 22.3% |
| Depreciation | 30.7 | 32.0 | 30.3 | 31.3 | 28.3 | 28.5 | 37.8 | 40.1 |
| EBITA | 71.4 | 71.4 | 86.5 | 58.8 | 114.0 | 90.9 | 114.6 | 140.5 |
| EBITA margin | 8.9% | 9.9% | 11.9% | 7.4% | 13.6% | 10.8% | 13.3% | 17.3% |
| Amortization of intangibles | 14.2 | 8.4 | 7.2 | 7.2 | 7.2 | 7.0 | 4.6 | 3.5 |
| EBIT [+] | 57.2 | 63.0 | 79.2 | 51.5 | 106.8 | 83.9 | 110.0 | 137.0 |
| EBIT growth | -9.2% | -20.5% | 53.8% | -51.8% | 27.3% | -23.7% | -19.7% | 43.6% |
| EBIT margin | 7.1% | 8.7% | 10.9% | 6.5% | 12.7% | 9.9% | 12.8% | 16.9% |
| Interest expense, net [+] | 14.3 | 6.7 | 7.9 | 5.8 | 4.4 | 4.4 | 6.0 | 5.7 |
| Interest expense | 14.4 | 6.8 | 8.0 | 5.9 | 4.4 | 4.4 | 6.0 | 5.7 |
| Interest income | 0.1 | 0.1 | 0.1 | 0.1 | | | | |
| Other income (expense), net [+] | 0.3 | 0.3 | -1.0 | -5.6 | -5.1 | -3.2 | 2.0 | -0.9 |
| Gain (loss) on foreign currency transactions | 0.5 | -0.6 | 1.1 | 3.9 | 5.1 | 3.2 | -2.0 | 0.9 |
| Pre-tax income | 43.2 | 56.6 | 70.3 | 40.1 | 97.4 | 76.2 | 106.0 | 130.4 |
| Income taxes | 7.2 | 34.2 | 22.3 | 13.8 | 32.9 | 26.7 | 31.8 | 43.9 |
| Tax rate | 16.6% | 60.4% | 31.8% | 34.3% | 33.8% | 35.1% | 30.0% | 33.7% |
| Net income | 35.9 | 22.4 | 47.7 | 26.3 | 64.3 | 49.4 | 74.2 | 86.5 |
| Net margin | 4.5% | 3.1% | 6.6% | 3.3% | 7.7% | 5.9% | 8.6% | 10.7% |
| |
| Basic EPS [+] | $1.84 | $1.15 | $2.47 | $1.31 | $2.96 | $2.25 | $3.40 | $3.99 |
| Growth | 60.1% | -53.5% | 88.6% | -55.6% | 31.2% | -33.7% | -14.7% | 89.3% |
| Diluted EPS [+] | $1.82 | $1.13 | $2.44 | $1.29 | $2.91 | $2.21 | $3.30 | $3.83 |
| Growth | 60.5% | -53.4% | 88.4% | -55.5% | 31.4% | -32.9% | -13.9% | 89.8% |
| |
| Dividends per share [+] | $1.93 | $1.93 | $1.93 | $1.92 | $1.76 | $1.45 | $0.89 | $1.00 |
| Growth | 0.0% | -0.2% | 0.6% | 9.1% | 21.4% | 62.9% | -11.0% | 47.1% |
| |
| Shares outstanding (basic) [+] | 19.5 | 19.4 | 19.3 | 20.0 | 21.8 | 21.9 | 21.8 | 21.7 |
| Growth | 0.4% | 0.9% | -3.8% | -7.9% | -0.8% | 0.6% | 0.5% | 1.3% |
| Shares outstanding (diluted) [+] | 19.8 | 19.7 | 19.6 | 20.3 | 22.1 | 22.3 | 22.5 | 22.6 |
| Growth | 0.1% | 0.8% | -3.7% | -8.1% | -1.0% | -0.6% | -0.5% | 1.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|